Answer:
Throughout the experiment at hand, the student will likely find that root space does indeed effect the length to which plantswill grow. Although I could not locate the table online, I will offer a general hypothesis for what the experiment will conclude. The student is testing the effects of root space on the way plants grow. The students experiment is well designed, keeping many variables constant and making sure that the amount of root spaceis the only difference between the plantsensures the accuracy of the experiment. Since we know that the experiment is well designed we are able to directly infer the effects of root space limitations without having to account for other factors. We can assume that the limited root space will in turn limit the extent to which a plant can grow. This is because plants need larger and deeper roots to support extended growth. Therefore, the plants in group Bwill grow smaller than those in group A.
Explanation:
mark me brainliest!!
I think the correct answer is d
A dependent variable is one whose value depends on another variable. Hope that helps you answer the question!
Answer:
Abstract
Down syndrome (DS) is associated with aberrations in genetic, morphological, biochemical and physiological characteristics. A number of genes located on human chromosome 21 (HSA21) encode proteins which are thought to be involved in numerous metabolic pathways, e.g., phosphofructokinase, cystathionine β-synthase etc. Perturbations of the metabolic pathways may lead to altered drug metabolism in DS individuals. We present a review of metabolic aberrations linked to HSA21 genes in DS. We particularly focus on drug disposition, efficacy, sensitivity and toxicity of anti-leukaemic agents including methotrexate, glucocorticoids, anthracyclines and cytarabine in DS leukaemia. The different outcomes of therapy due to differential drug response, varied drug toxicity and treatment related mortality in DS leukaemia is a subject of much research and speculation. Altered drug response in DS individuals may stem from differences in pharmacokinetics, pharmacodynamics and pharmacogenetics. Further large-cohort studies in different age groups dissecting metabolic and molecular pathways involved in drug response may increase our understanding in this regard and stipulate pharmacotherapies in DS.
